BioActor and Jaeckering sign Joint Development & Marketing Agreement on wheat extract

Brussels, Belgium/Hamm, Germany, December 1st, 2005

Press release
BioActor and Jaeckering announced today a new collaboration agreement that combines Jaeckering’s know-how to extract bioactives from wheat fractions and BioActor’s know-how in the development and marketing of ingredients for functional food to counteract metabolic syndrome.

Wheat arabinoxylan extract

Collaboration targets novel wheat-based functional ingredients to counteract the metabolic syndrome.

BioActor BVBA (BioActor) and Jaeckering Muehlen-u. Naehrmittelwerke GmbH (Jaeckering) announced today that they have signed a collaboration agreement that combines Jaeckering’s know-how to extract bioactives from wheat fractions and BioActor’s know-how in the development and marketing of ingredients for functional foods. Under the terms of the agreement, BioActor will exclusively market Jaeckering’s innovative pentosan concentrate and parties will actively explore additional opportunities around wheat-based bioactives.JAECKERING in collaboration with Professor Meuser of TU Berlin has developed a proprietary production process to extract wheat pentosans from a starch production sidestream. The resulting soluble fibre product has been validated for its contribution to glycaemic control in humans by the German Institute of Human Nutrition, PotsdamRehbruecke.

According to Hans van der Saag, BioActor CEO, « together with our partner Jaeckering we will exploit the yet untapped potential of wheat for the improvement of human health. We see great opportunities for speciality wheat-based products in combat against metabolic syndrome. Jaeckering’s speciality pentosan concentrate that we will market under the brand NAXUS® has been clinically tested for improved glycaemic control and has excellent food technological properties. Moreover, Jaeckering’s manufacturing prowess acquired over the past 100 years, will greatly help us in developing new and innovative wheat-based health ingredients».

Michel Andreae Jaeckering, CEO of JAECKERING GRUPPE commented that «We are very pleased to have entered into this collaboration with BioActor, a technology company fully focussed on the health ingredients sector. We expect that our collaboration will accelerate the market introduction of our pentosan product and will lead to the introduction of additional new health ingredients».

Jäckering is a major German wheat processor with more than 200.000 tons per annum Wheat grinding capacity and more than 100.000 tons p.a. wheat starch production facilities. Jäckering also produces and markets innovative grinding and drying technology under the brand name ULTRA ROTOR.

About BioActor

BioActor, based in Maastricht, Netherlands, is a product development company that has developed a range of proprietary bioactive ingredients for the nutrition & healthcare industry. The company focuses on the development of innovative activities that address active living and healthy aging. The goal is to provide the nutrition & healthcare industry with science-based innovations that confer a real health benefit to the consumer.

Feel free to contact us via info@bioactor.com for more information.